Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 14, Number 1—January 2008
THEME ISSUE
International Polar Year

Dispatch

Implementation and Effectiveness of Antiretroviral Therapy in Greenland

Nicolai Lohse*†Comments to Author , Karin Ladefoged‡, and Niels Obel†1
Author affiliations: *Århus University Hospital, Århus, Denmark; †Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark; ‡Dronning Ingrids Hospital, Nuuk, Greenland;

Main Article

Figure 1

Proportion of patients receiving treatment on January 1, 1996–2006 in A) Denmark and B) Greenland. Numerator, patients who were receiving antiretroviral therapy as part of a HAART (highly active antiretroviral therapy) regimen. Denominator, all patients under observation. NNRTI, non-nucleoside reverse transcriptase inhibitor; PI, protease inhibitor.

Figure 1. Proportion of patients receiving treatment on January 1, 1996–2006 in A) Denmark and B) Greenland. Numerator, patients who were receiving antiretroviral therapy as part of a HAART (highly active antiretroviral therapy) regimen. Denominator, all patients under observation. NNRTI, non-nucleoside reverse transcriptase inhibitor; PI, protease inhibitor.

Main Article

1The Danish HIV Cohort Study: Departments of Infectious Diseases at Copenhagen University Hospitals Rigshospitalet (J. Gerstoft, N. Obel) and Hvidovre (G. Kronborg), Odense University Hospital (C. Pedersen), Aarhus University Hospitals, Skejby (C.S. Larsen) and Aalborg (G. Pedersen), Herning Hospital (A.L. Laursen), Helsingør Hospital (B. Kvinesdal), and Kolding Hospital (A. Møller).

TOP